2020 SEP 30 HCQ use reduces the incidence of COVID-19 infection, hospitalization, and death
Hydroxychloroquine use in outpatients reduces the incidence of the composite outcome of COVID-19 infection, hospitalization, and death. Serious adverse events were not reported and cardiac arrhythmia was rare. Systematic review registration–This review was not registered. Continue Reading